Cargando…
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients
BACKGROUND: TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (siRNA) siLpol-2 and siVP35-2. The pharmacokinetics (PK) of these siRNAs was defined in Ebola virus disease (EVD) patients, with reference to efficacy (ET) and toxicology thresholds (TT). The relations...
Autores principales: | Scott, Janet T., Sharma, Raman, Meredith, Luke W., Dunning, Jake, Moore, Catrin E., Sahr, Foday, Ward, Steve, Goodfellow, Ian, Horby, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033524/ https://www.ncbi.nlm.nih.gov/pubmed/31953031 http://dx.doi.org/10.1016/j.ebiom.2019.102601 |
Ejemplares similares
-
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
por: Dunning, Jake, et al.
Publicado: (2016) -
Reporting in a health emergency: The roles of Sierra Leonean journalists during the 2014-2015 Ebola outbreak
por: Winters, Maike, et al.
Publicado: (2020) -
Post-Ebola Syndrome, Sierra Leone
por: Scott, Janet T., et al.
Publicado: (2016) -
Tkm-ebola: Fever, rigours and deterioration Ebola virus disease: 2 case reports
Publicado: (2015) -
Epidemiological characteristics, clinical manifestations, and treatment outcome of 139 paediatric Ebola patients treated at a Sierra Leone Ebola treatment center
por: Kangbai, Jia Bainga, et al.
Publicado: (2019)